Trial Profile
PIONEER: A Phase I Study of Olaparib in Combination with Chemo-radiation in Locally Advanced Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Sep 2023
Price :
$35
*
At a glance
- Drugs Olaparib (Primary) ; Capecitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Acronyms PIONEER
- 03 Aug 2022 Status changed from suspended to completed.
- 01 May 2020 Status changed to suspended.
- 08 Apr 2020 Planned End Date changed from 30 Apr 2019 to 31 Jul 2022.